News | February 07, 2024
IOL Chemicals and Pharmaceuticals net profit rises 43.5% in 9M FY24
The company recently received CEP certificate approval for Losartan Potassium by EDQM
The company recently received CEP certificate approval for Losartan Potassium by EDQM
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
At least one recognised startup in every State and UT; spread across over 80% of districts
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Combines biocompatibility, heat-resistance, transparency and durability
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
The new campus has been designed as an employee-centred experience and ecosystem zone
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Subscribe To Our Newsletter & Stay Updated
